{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:27:36Z","timestamp":1763036856379},"reference-count":24,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,10,17]],"date-time":"2014-10-17T00:00:00Z","timestamp":1413504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Uncontrolled hyperthyroidism in pregnancy poses a risk to both mother and foetus, and the optimal treatment strategy in this setting remains elusive. Instigation of pharmacological therapy or an alternative intervention during pregnancy requires careful consideration, and the evidence that has underpinned our choice of antithyroid drug has not been robust. Recent research developments have prompted us to question our practice, and reconsider our approach to managing this patient group.<\/jats:p>","DOI":"10.1111\/cen.12577","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T16:03:27Z","timestamp":1407254607000},"page":"475-477","source":"Crossref","is-referenced-by-count":4,"title":["Rethinking antithyroid drugs in pregnancy"],"prefix":"10.1111","volume":"82","author":[{"given":"C.","family":"Napier","sequence":"first","affiliation":[{"name":"Institute of Genetic Medicine  Newcastle University and Endocrine Unit Newcastle upon Tyne Hospitals Newcastle upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.S.","family":"Pearce","sequence":"additional","affiliation":[{"name":"Institute of Genetic Medicine  Newcastle University and Endocrine Unit Newcastle upon Tyne Hospitals Newcastle upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,10,17]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0801880"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010263431707"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60782-4"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e328357f3d5"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0663"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000329186"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.9.3099"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0652"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420050117"},{"key":"e_1_2_4_11_1","first-page":"1264","article-title":"Aplasia cutis congenital and methimazole","volume":"130","author":"Bachrach L.K.","year":"1984","journal-title":"Canadian Medical Association Journal"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1994.4.129"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8126"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.20668"},{"key":"e_1_2_4_15_1","unstructured":"UK Guidelines for the Use of Thyroid Function Tests(2006). Available from:www.british-thyroid-association.org(accessed 29 May 2014)."},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0141"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2546"},{"key":"e_1_2_4_18_1","volume-title":"FDA Drug Safety Communication New Boxed Warning on Severe Liver Injury with Propylthiouracil","year":"2010"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.0087"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2803"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2831"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2860"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0488"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03469.x"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000342920"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcen.12577","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.12577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T08:56:24Z","timestamp":1695545784000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.12577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,17]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1111\/cen.12577"],"URL":"https:\/\/doi.org\/10.1111\/cen.12577","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,17]]}}}